Article Source : Natural Health Research Institute Written by Angeline A. De Leon, Staff Writer. Eight weeks of supplementation with tocotrienol improved diabetic peripheral neuropathy (DPN) in participating subjects compared to placebo. Characterized by pain and numbness in the extremities, DPN is a complication associated with type 2 diabetes and the most common type of... View Article
The incidence of aspirin resistance was significantly decreased in patients taking aspirin and clopidogrel with supplementation of tocotrienol. This important finding was observed in the NUTRITION Trial – a randomized double-blind human clinical trial conducted at the Ohio State University Medical Center, in collaboration with the Malaysia Palm Oil Board. The NUTRITION human clinical trial... View Article
This post was originally published on December 1, 2016 and updated on June 11, 2020. A new and interesting cross-sectional study of 2118 women and men, age stratified from 35 to 74 years and recruited from six European countries, was recently published. In this study, the researchers reviewed and examined plasma carotenoids (alpha- and beta-carotene, lutein, zeaxanthin,... View Article
Oral EVNol™ supplementation protects against retinal degenerative changes, as demonstrated in an in vivo study published in the journal Biomolecules. Diabetic retinopathy (DR) is one of several diabetes related complications and now is the leading cause of new onset blindness among individuals aged 20 to 64 years old. In the study, the Streptozotocin-induced diabetic rats... View Article
Twelve weeks of supplementation with EVNol SupraBio significantly improved renal function in diabetic nephropathy patients, as demonstrated in a study published in Therapeutic Advances in Endocrinology and Metabolism (1). This prospective, multicenter, double-blinded, placebo-controlled study was conducted by a group researchers from the Jeffrey Cheah School of Medicine and Health Sciences, Monash University (Malaysia Campus). Diabetic nephropathy... View Article
Twelve weeks supplementation of EVNol SupraBio™ significantly improved renal function in diabetic nephropathy patients, as demonstrated in a study published in Therapeutic Advances in Endocrinology and Metabolism(1). This prospective, multicenter, double-blinded, placebo-controlled study was conducted by a group researcher from the Jeffrey Cheah School of Medicine and Health Sciences, Monash University (Malaysia Campus). Diabetic nephropathy... View Article
A novel pathway for tocotrienol-mediated neuroprotection in primary hippocampal neurons was elucidated in a latest study published in International Journal of Molecular Sciences (1). The collaborative study was conducted by a group of researchers from Yale University and University of Alabama. This exciting new study further adds to the foundation of non-antioxidant pathway elucidated by... View Article
